)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
EBOS Group
EBOS Group (EBO) investor relations material
EBOS Group H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary24 Feb, 2026
Executive summary
Revenue for H1 FY26 grew 13% year-over-year to AUD 6.77 billion, driven by strong Healthcare and Animal Care performance and recent acquisitions.
Underlying EBITDA increased 3.2% to AUD 300 million, with statutory EBITDA up 9.7% to AUD 303 million; NPAT was AUD 125 million (statutory +13%).
Interim dividend maintained at NZD 0.57 per share, payout ratio 82% of underlying NPAT, payable 27 March 2026.
Bolt-on acquisitions totaling AUD 70 million were completed, expanding Medical Technology and pharmacy reach, with early positive trading results.
The business is well-positioned for FY 2027, with revenue momentum from network growth, innovation, and regional expansion.
Financial highlights
Revenue grew 13% year-over-year to AUD 6.8 billion for the half, reflecting strong momentum in both Healthcare and Animal Care.
Underlying EBITDA increased to AUD 300 million (+3.2%), and underlying NPAT was AUD 125 million, slightly down due to DC Renewal Program impacts.
Statutory NPAT rose 13% to AUD 125 million, benefiting from reduced non-recurring costs.
Underlying EPS was AUD 0.614; ROCE at 12.9%, impacted by ongoing capital investment.
Net cash inflow from operating activities was AUD 46.6 million, down from AUD 189.8 million year-over-year.
Outlook and guidance
FY26 underlying EBITDA guidance reaffirmed at AUD 615–635 million, with growth weighted to H2 and expectations to finish at the top end.
CapEx for the half was AUD 70 million; full-year CapEx guidance unchanged, with a 30% reduction expected in FY27 as the capital cycle ends.
Second half of FY26 expected to see EBITDA of AUD 315–335 million, driven by full-period contributions from acquisitions and productivity gains.
Margin improvement and cash flow growth anticipated in FY27 as DCs reach steady state and D&A and interest normalize.
Board expects continued growth, supported by recent acquisitions and expanded product offerings.
ABT Nevada LLC control: financial impact?
Analyze segment profitability drivers.
How did the bank facility refinance impact debt maturity?
Quantify DC renewal program's FY27 EBITDA uplift?
GLP-1 & CSO: What's the combined margin impact?
Future capital deployment strategy post-capex peak
OpEx % of revenue target for steady state DCs?
Core margin outlook beyond CSO uplift in FY27?
MediAdvice integration strategy and banner plans?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next EBOS Group earnings date
Investor Day 202629 Apr, 2026
EBOS Group
Next EBOS Group earnings date
Investor Day 202629 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
EBOS Group Limited is a healthcare and animal care company involved in the distribution, marketing, and wholesaling of medical, pharmaceutical, and veterinary products. The company supplies a broad range of products and services, including pharmaceuticals, medical consumables, and equipment to hospitals, pharmacies, and healthcare providers. Additionally, EBOS operates in the animal care sector, offering pet food, healthcare products, and veterinary services. The company emphasizes operational efficiency and quality in its distribution network, supporting healthcare and veterinary sectors in Australia and New Zealand. The company is headquartered in Christchurch, New Zealand, and its shares are listed on the NZX and ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage